Meeting
2015 ASCO Annual Meeting
Evaluation of tumor MET protein expression, MET gene amplification, and HER2 expression in Chinese patients with advanced gastric or gastroesophageal junction (G/GEJ) cancer.
Authors
Rui-hua Xu
Sun Yat-Sen University Cancer Center, Guangzhou, China
Rui-hua Xu , Miaozhen Qiu , Yi-xin Zhou , De-Shen Wang , Dong-sheng Zhang , Fenghua Wang , Yu-hong Li , Jacqueline Huang , Hui Zhou , En-Tzu Tang , Zhiqiang Du , Fanny Zhang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Noncolorectal) Cancer
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Esophageal or Gastric Cancer
Citation
J Clin Oncol 33, 2015 (suppl; abstr 4048)
DOI
10.1200/jco.2015.33.15_suppl.4048
Abstract #
4048
Poster Bd #
158
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
Prognostic value of HER2 expression levels for upper tract urothelial carcinoma.
First Author: Siming Li
Poster
2013 Gastrointestinal Cancers Symposium
Differential HER2 expression in resected gastric cancer: Is there prognostic value?
First Author: Sarah Fisher
Poster
2024 ASCO Breakthrough
Differences in the expression heterogeneity of ADC-related markers between primary tumors and metastatic lymph nodes in advanced urothelial cancers.
First Author: Xingliang Tan
Poster
2023 ASCO Annual Meeting
Trastuzumab emtansine (T-DM1) in advanced cancers with HER2 mutations or amplification: Results from the Molecular Screening and Therapeutics (MoST) Program substudy.
First Author: Subotheni Thavaneswaran